HIV Medicine

Papers
(The H4-Index of HIV Medicine is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information94
84
Issue Information83
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends75
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration51
48
The characteristics of men who have sex with men (MSM) using post‐exposure prophylaxis for sexual exposure (PEPSE) in the pre‐exposure prophylaxis (PrEP) era45
45
Effect of an opt‐out point‐of‐care HIV‐1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomiz40
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV38
Reflections on a specialist HIV menopause service37
The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV32
Issue Information32
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project30
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group30
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms29
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany29
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina27
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany26
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil25
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study21
0.047318935394287